MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by PHILPOT, R. M.
Right arrow Articles by SERABJIT-SINGH, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by PHILPOT, R. M.
Right arrow Articles by SERABJIT-SINGH, C.

Molecular Pharmacology, Vol 12, 483-493, Copyright © 1976 by the American Society for Pharmacology and Experimental Therapeutics

Separation and Purification of Two Forms of Hepatic Cytochrome P-450 from Untreated Rabbits

R. M. PHILPOT 1, EMEL ARINÇ 1, and COSETTE SERABJIT-SINGH 1

1 Pharmacology Branch, National Institute of Environmental Health Sciences, Research Triangle Park, North Carolina 27709

Two forms of hepatic cytochrome P-450 have been separated and partially purified from untreated rabbits. The carbon monoxide-reduced minus reduced difference spectrum of one form (A) had a peak of absorption at 450.2 nm while the same spectrum of the other form (B) gave a peak at 448 nm. Differences in the spectral properties of the two forms of the cytochrome were also seen in the Soret region of the spectra of oxidized preparations, in the Soret and visible regions of the spectra of reduced preparations complexed with carbon monoxide, and in the difference spectra formed by the addition of type I and type II compounds. The cytochromes were purified to 6.5 and 14.3 nmoles/mg of protein for forms A and B, respectively. The partially purified preparations were free of cytochrome b5 and had barely detectable concentrations of NADPH-cytochrome c reductase, epoxide hydrase, and cytochrome P-420. The cytochrome in fraction A was about twice as active as the cytochrome in fraction B in support of benzpyrene hydroxylase, benzphetamine N-demethylase, and 7-ethoxycoumarin O-deethylase activities when combined with NADPH-cytochrome c reductase and lipid fractions. Monomeric molecular weights for both forms of the cytochrome were estimated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis to be near 51,500.

Note:
ACKNOWLEDGMENTS The authors are indebted to Dr. J. R. Fouts, Chief, Pharmacology Branch, National Institute of Environmental Health Sciences, for his support and encouragement, and to Mr. Gary Foureman for determining epoxide hydrase activities.

Submitted on November 4, 1975







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1976 by the American Society for Pharmacology and Experimental Therapeutics